Trials
Search / Trial NCT06435949

Effect of Oxycodone on Anxiety State in Painless Abortion

Launched by RUIJIN HOSPITAL · May 24, 2024

Trial Information

Current as of February 08, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This study is a multicenter, randomized controlled clinical study. A total of 300 patients who underwent elective painless abortion surgery in Ruijin Hospital and other sub-central hospitals were enrolled, and they were randomly divided into 1:1 patients who received intravenous anesthesia with propofol with fentanyl (group F) and propofol with oxycodone (group O). The scores of anxiety, depression and postoperative numerical rating scale (NRS) before and after surgery were observed, and the levels of serum stress response factors and inflammatory cytokines were monitored. The effects of ox...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-45 years old
  • Gestational age 6-12 weeks
  • American Society of Anesthesiologists (ASA) Grading I-II
  • Fluent communicator and able to complete self-rating scales on her own
  • Voluntarily participate and sign the informed consent form
  • Exclusion Criteria:
  • Patients who are allergic to anesthetic drugs such as propofol, oxycodone, fentanyl, etc., or who have had other anesthetic adverse events
  • Patients with anxiety or depression
  • Presence of organic mental disorders, mental retardation
  • Severe acute and chronic infection, severe heart, liver and kidney insufficiency
  • Patients with complications or bleeding \> 50ml during surgery

About Ruijin Hospital

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution in China recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, Ruijin Hospital integrates cutting-edge medical practices with rigorous scientific investigation. The hospital's multidisciplinary teams are dedicated to developing new therapeutic approaches, improving patient outcomes, and contributing to global medical knowledge. As a sponsor of clinical trials, Ruijin Hospital ensures adherence to the highest ethical standards and regulatory compliance, fostering an environment of collaboration and excellence in clinical research.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0